Possible Threats of IgA Vasculitis in Children: One Center Experience
Acta medica Lituanica · 26.12.2024 · 31 (2) · 254-263
DOI: 10.15388/amed.2024.31.2.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta medica Lituanica, online erschienen am 26.12.2024. Verfasst von Eglė Lanzbergaitė-Manuilova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Center, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
Immunoglobulin A vasculitis (IgAV) is the most common vasculitis in children. Although typically self-limiting, IgAV may result in serious complications. Our objective was to evaluate the incidence, clinical features, laboratory predictors and outcomes of IgA vasculitis with gastrointestinal (GI) and kidney involvement.
Methods
Medical records of patients
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatric Center, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
ORCID-Profile: Eglė Lanzbergaitė-Manuilova, Skirmantė Rusonienė, Augustina Jankauskienė
Zitieren
APA
Lanzbergaitė-Manuilova, E., Rusonienė, S., & Jankauskienė, A. (2024). Possible Threats of IgA Vasculitis in Children: One Center Experience. Acta medica Lituanica, 31(2), 254-263. https://doi.org/10.15388/amed.2024.31.2.4
Vancouver
Lanzbergaitė-Manuilova E, Rusonienė S, Jankauskienė A. Possible Threats of IgA Vasculitis in Children: One Center Experience. Acta medica Lituanica. 2024;31(2):254-263. doi:10.15388/amed.2024.31.2.4
BibTeX
@article{LanzbergaitManuilova2024,
author = {Lanzbergaitė-Manuilova, Eglė and Rusonienė, Skirmantė and Jankauskienė, Augustina},
title = {Possible Threats of IgA Vasculitis in Children: One Center Experience},
journal = {Acta medica Lituanica},
year = {2024},
volume = {31},
number = {2},
pages = {254--263},
doi = {10.15388/amed.2024.31.2.4}
}
EUVIMED